TY - CONF T1 - Long-term dupilumab treatment is not associated with an increased overall risk of infections in patients aged 6 months to 5 years with moderate-to- severe atopic dermatitis in an open-label extension study JO - PEDIATRIC ALLERGY AND IMMUNOLOGY PY - 2024/01/01 AU - Paller AS AU - Ramien M AU - Cork MJ AU - Simpson EL AU - Lee LW AU - Eichenfield LF AU - Silva D AU - Coleman A AU - Gherardi G AU - Chen Z AU - Zhang A et al ED - VL - 35 Y2 - 2025/05/18 ER -